Finally, Chia-Hsiung et al. [220] presented evidence that Plasmon-Activated Water (PAW) reduces β-amyloid and P-Tau burden in murine models of AD (APP/PS1), improving the behavioral parameters. The gene discussed is MAPT; the disease is Alzheimer disease.